Modeling the antigenic evolution of seasonal influenza viruses with PREDAC for vaccine strain selection in the season of 2025
Peng, Y.; Du, X.; Liu, M.; Ding, X.; Meng, J.; Han, W.; Yang, L.; Huang, W.; Jiang, T.; Wang, D.
Show abstract
IntroductionThe antigenic evolution of seasonal influenza viruses have been reported to be discontinuous as clusters. Timely identification of antigenic clusters could help for influenza virus vaccine strain selections. MethodsHere, we revealed the antigenic evolution of seasonal influenza viruses, including A(H3N2), A(H1N1pdm) and B-Victoria, using our previously developed PREDAC methods, and identified antigenic clusters of seasonal influenza viruses based on existing HA protein sequences in GISAID database. ResultsDuring the last six months (2024.2[~]2024.7), for the influenza A(H3N2) virus, the antigenic clusters DA21 (A/Darwin/6/2021-like and A/Massachusetts/18/2022-like) continuously dominated and nearly all viruses are antigenic similar to the current vaccine strain A/Massachusetts/18/2022; for the influenza A(H1N1pdm) virus, the antigenic cluster SY21 (A/Sydney/5/2021-like and A/Victoria/4897/2022-like) dominated and nearly all viruses are antigenic similar to the current vaccine strain A/Victoria/4897/2022; for the influenza B-Victoria, antigenic clusters AU21 (B/Austria/1359417/2021-like) dominated and nearly all viruses are antigenic similar to the current vaccine strain B/Austria/1359417/2021. ConclusionThe analysis suggests that there is no need to update the vaccine strains in the flu season of 2025 on the aspect of antigenicity.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The role of viral interference in shaping RSV epidemics following the 2009 H1N1 influenza pandemic 93%
- Interactions among common non-SARS-CoV-2 respiratory viruses and influence of the COVID-19 pandemic on their circulation in New York City 92%
- Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 91%
Similar papers in this journal
- An interactive viral genome evolution network analysis system enabling rapid large-scale molecular tracing of SARS-CoV-2 94%
- A live attenuated influenza virus-vectored intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 infection 91%
- The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2 90%
Similar papers in this journal
- Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2 95%
- Neutralization of Omicron BA.4/BA.5 and BA.2.75 by Booster Vaccination or BA.2 Breakthrough Infection Sera 93%
- One year landscape of the inactivated virus vaccine triggered RBD-specific IgG, IgM and IgA responses against the Omicron variant 92%
Similar papers in this journal
- Antibody neutralization to SARS-CoV-2 and variants after one year in Wuhan 93%
- Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China 92%
- What is required to prevent a second major outbreak of the novel coronavirus SARS-CoV-2 upon lifting the metropolitan-wide quarantine of Wuhan city, China 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.